Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Biogen Idec's first incubator play

Biogen Idec Inc. created its Biogen Idec Innovation Incubator, bi3, to allow entrepreneurial scientists access to BIIB's resources and experience in drug development, with the goal of invigorating its early stage pipeline. After screening nearly 100 ideas, Columbia University spinout Escoublac Inc. was selected as the first entry into bi3.

BIIB formed bi3 this year, and BIIB spokesperson Amy Reilly said

Read the full 604 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers